Average Co-Inventor Count = 11.51
ph-index = 10
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Janssen Biotech, Inc. (32 from 410 patents)
2. Applied Molecular Evolution (9 from 27 patents)
3. Other (1 from 832,680 patents)
4. Janssen Pharmaceutica Nv (1 from 2,076 patents)
5. New York University (1 from 1,624 patents)
6. Centocor, Inc. (1 from 144 patents)
7. Centocor Ortho Biotech Inc. (1 from 31 patents)
36 patents:
1. 12173064 - Antibodies specifically binding PD-1, TIM-3 or PD-1 and TIM-3 and their uses
2. 12065488 - Anti-IL-6 antibody
3. 11866499 - Monospecific and multispecific anti-TMEFF2 antibodies and their uses
4. 11180549 - Methods of suppressing rheumatoid arthritis using an anti-IL-6 antibody
5. 10894830 - Antibodies specifically binding PD-1, TIM-3 or PD-1 and TIM-3 and their uses
6. 10844122 - Prostate specific membrane antigen (PSMA) bispecific binding agents and uses thereof
7. 10781246 - Compositions and methods for anti-staphylococcal biologic agents
8. 10450377 - ST2L antagonists and methods of use
9. 10196440 - Anti-PHG-tau antibodies and their uses
10. 10000559 - Anti-PHF-tau antibodies and their uses
11. 9951137 - ST2L antagonists and methods of use
12. 9932404 - Methods of reducing clinical symptoms of viral infection by administering a toll-like receptor 3 antagonist
13. 9850310 - CD123 binding agents and uses thereof
14. 9745371 - Anti-PHF-tau antibodies and their uses
15. 9631016 - Pen-injector device containing anti-IL-6 antibodies